Skip to main content
See every side of every news story
Published loading...Updated

'Objectively unreasonable’: Onego Bio slams The Every Co in high-stakes patent fight

Summary by AgFunderNews
Onego Bio—a startup producing egg proteins via precision fermentation—has launched legal action in a bid to invalidate a key patent granted to rival The Every Company. According to Onego Bio, The Every Co has demanded “unwarranted patent licensing fees” from Onego and engaged in tortious interference by telling third parties, including potential investors, that “Onego needs a patent license from Every or Onego would be infringing Every’s patents…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

AgFunderNews broke the news in on Thursday, September 11, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal